PLUS1
0.41
0.01 (2.5%)
0.01 (2.5%)
Upgrade to Real-Time
Market Closed
Low
0.16
High
0.64
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Avicanna Inc | AVCN | Toronto | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.01 | 2.5% | 0.41 | 15:59:59 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.40 | 0.40 | 0.41 | 0.41 | 0.40 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 5 | 3,350 | - | 0.16 - 0.64 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:58:59 | 500 | $ 0.41 | CAD |
Period:
Draw Mode:
Avicanna Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 29.81M | 52.62M | 52.62M | $ 3.27M | $ 0.00 | -0.46 | -1.30 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 11.43k | $ - | - | 0.00 | - |
Avicanna News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AVCN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.435 | 0.435 | 0.38 | 0.3966532 | 9,343 | -0.025 | -5.75% |
| 1 Month | 0.35 | 0.56 | 0.35 | 0.4503999 | 69,097 | 0.06 | 17.14% |
| 3 Months | 0.30 | 0.56 | 0.25 | 0.3450069 | 103,726 | 0.11 | 36.67% |
| 6 Months | 0.325 | 0.56 | 0.25 | 0.3442525 | 63,924 | 0.085 | 26.15% |
| 1 Year | 0.445 | 0.64 | 0.16 | 0.3473525 | 55,530 | -0.035 | -7.87% |
| 3 Years | 2.40 | 2.40 | 0.16 | 0.8718107 | 51,110 | -1.99 | -82.92% |
| 5 Years | 7.40 | 7.40 | 0.16 | 1.47 | 57,286 | -6.99 | -94.46% |
Avicanna Description
| Avicanna is an innovative, commercial-stage, and international biopharmaceutical company focused on the development, advancement, and commercialization of evidence-based cannabinoid-based products... |